Most previous studies of MASH and its associated hepatocellular carcinoma have focused on clinical studies in obese Western people or in animals with severe obesity or fed on special diets, with the idea that excessive insulin action due to hyperinsulinemia is involved in the pathogenesis of the disease. The gene discussed is INS; the disease is metabolic dysfunction-associated steatohepatitis.